SINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

SHOULDER INNOVATIONS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$18.25+0.16 (+0.88%)

Close on Oct 19, 2026

Market cap: $378.43M
P/E (TTM): –
Dividend yield: –

SHOULDER INNOVATIONS, INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31
Revenue	47	32
Cost of Revenue	11	7.28
Gross Profit	36	24
Research & Development	7.73	4.49
Selling, General & Admin	55	35
Advertising Expenses	1.18	0.87
Operating Income	-26	-15
Interest Expense	0.07	1.32
Interest & Investment Income	1.95	0.77
Other Non-Operating Income	-14	-0.97
Gain (Loss) on Sale of Assets	-0.10	-0.04
Pretax Income	-40	-16
Income Tax Expense	0	0
Net Income	-40	-16
Preferred Dividends	0	0
EPS (Basic)(per share)	-4.65	-242.04
EPS (Diluted)(per share)	-4.65	-242.04
Shares Outstanding (Basic, Weighted)(shares)	8.67	0.06
Shares Outstanding (Diluted, Weighted)(shares)	8.67	0.06

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 77.3%
Operating margin: -58.5%
Net margin: -58.3%
Return on equity, FY2025: -93.8%

Financial strength

Current ratio: 10.71
Debt to equity: 0.12
Debt to assets: 9.7%
Cash to current liabilities: 190.6%

Valuation

P/E ratio: –
Price to sales: 6.30
Price to book: 3.04
Dividend yield: –